3B2W

Crystal structure of pyrimidine amide 11 bound to Lck

3B2W の概要

• エントリーDOI: 10.2210/pdb3b2w/pdb
• 関連するPDBエントリー: 2OFV
• 分子名称: Proto-oncogene tyrosine-protein kinase LCK, N-[5-({[2-fluoro-3-(trifluoromethyl)phenyl]amino}carbonyl)-2-methylphenyl]-4-methoxy-2-[(4-piperazin-1-ylphenyl)amino]pyrimidine-5-carboxamide (3 entities in total)
• 機能のキーワード: lck, kinase domain, alternative splicing, atp-binding, chromosomal rearrangement, cytoplasm, disease mutation, host-virus interaction, lipoprotein, membrane, myristate, nucleotide-binding, palmitate, phosphorylation, proto-oncogene, sh2 domain, sh3 domain, transferase, tyrosine-protein kinase
• 由来する生物種: Homo sapiens (human)
• 細胞内の位置: Cytoplasm: P06239
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 32682.26

構造登録者

Huang, X. (登録日: 2007-10-19, 公開日: 2007-12-18, 最終更新日: 2023-08-30)

• 主引用文献: Deak, H.L.,Newcomb, J.R.,Nunes, J.J.,Boucher, C.,Cheng, A.C.,DiMauro, E.F.,Epstein, L.F.,Gallant, P.,Hodous, B.L.,Huang, X.,Lee, J.H.,Patel, V.F.,Schneider, S.,Turci, S.M.,Zhu, X.; N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR.; Bioorg.Med.Chem.Lett., 18:1172-1176, 2008; PubMed: 18083554; DOI: 10.1016/j.bmcl.2007.11.123

実験手法

X-RAY DIFFRACTION (2.3 Å)